https://news.thecrimsonreport.com/story/618308/cutaneous-squamous-cell-carcinoma-clinical-trial-pipeline-appears-robust-with-45-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T16:55:17+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618307/atopic-dermatitis-clinical-trial-pipeline-appears-robust-with-100-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T16:52:57+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618306/dry-eye-disease-clinical-trial-pipeline-appears-robust-with-50-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T16:49:40+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618305/plaque-psoriasis-treatment-pipeline-shows-strong-momentum-as-75-pharma-companies-in-the-race-delveinsight.html 2026-04-29T16:47:29+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618303/autosomal-dominant-polycystic-kidney-disease-clinical-trial-pipeline-expands-as-13-companies-driving-innovation-in-the-therapeutics-delveinsight.html 2026-04-29T16:45:10+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618302/tenosynovial-giant-cell-tumors-clinical-trial-pipeline-accelerates-as-5-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html 2026-04-29T16:41:31+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618300/myasthenia-gravis-clinical-trial-pipeline-shows-potential-with-active-contributions-from-25-key-companies-delveinsight.html 2026-04-29T16:37:37+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618298/nonalcoholic-steatohepatitis-pipeline-set-for-transformational-expansion-by-2026-with-75-therapies-strong-clinical-momentum-from-novo-nordisk-viking-therapeutics-inventiva-pharma-delveinsight.html 2026-04-29T16:35:22+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618296/stat-inhibitors-pipeline-set-for-breakthrough-innovation-by-2026-with-22-therapies-and-expanding-clinical-momentum-delveinsight.html 2026-04-29T16:33:26+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618295/diabetic-neuropathy-pipeline-set-for-significant-breakthroughs-by-2026-with-20-therapies-and-robust-clinical-advancements-delveinsight.html 2026-04-29T16:31:15+00:00 daily 1.0